Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

4.79
Delayed Data
As of Sep 23
 +0.02 / +0.42%
Today’s Change
2.85
Today|||52-Week Range
7.18
-11.30%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close4.77
Today’s open4.77
Day’s range4.71 - 4.90
Volume119,902
Average volume (3 months)330,031
Market cap$144.4M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-27.86%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
CCMConcord Medical Serv...-0.17-4.28%
PMDPsychemedics Corp+0.09+0.46%
CPHRCipher Pharmaceutica...-0.09-2.28%
CDNACareDx Inc-0.06-1.57%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs